查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999159

生物製程容器市场：2026-2030年全球市场预测（按容器类型、材质、容量、灭菌方法、应用和最终用户划分）

Bioprocess Containers Market by Container Type, Material, Capacity, Sterilization Method, Application, End User - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年生物製程容器市场价值为 60.9 亿美元，预计到 2025 年将成长至 74 亿美元，复合年增长率为 22.33%，到 2030 年将达到 204.4 亿美元。

主要市场统计数据
基准年 2024 60.9亿美元
预计年份：2025年 74亿美元
预测年份 2030 204.4亿美元
复合年增长率 (%) 22.33%

本简要概述面向决策者，说明了生物製程容器在确保製程完整性、法规遵循和营运扩充性不断变化的作用。

生物工艺容器的现状正处于两大趋势的交汇点：快速的科学进步和日益严格的营运监管。随着生物製药研发和生产的不断发展，容器不再只是被动的容器，而是成为保障製程完整性、污染控制和供应链韧性的关键要素。这些容器支援从小规模科学实验到大规模契约製造的各种活动，其选择会影响工艺的可重复性、验证计划和下游物流。

关键的结构和技术变革正在重塑生物製程容器使用中的供应商动态、材料优先事项和监管预期。

在生物製程容器领域，正在发生多项变革性变化，这些变化正在重新定义供应商关係、设计优先顺序和采购逻辑。首先，向一次性系统和混合製程的加速转型迫使製造商和整合商优先考虑组件相容性、连接器标准化和供应连续性。这种演变正在重塑製药开发商进行製程转移和技术合格的方式，并对验证策略和供应商审核产生连锁反应。

2025 年的关税趋势将如何重新评估整个生物製程容器价值链的采购选择、供应商选择要求和供应链弹性策略？

已发表的2025年关税措施和贸易政策变化对生物製程容器生态系统产生了多方面的影响，包括采购决策、成本结构和供应商选址规划。对于依赖跨境供应链的企业而言，关税上调将提高进口零件和成品容器的实际接收成本，从而挤压利润空间，迫使买家重新审视其供应商选择标准。为此，许多买家正在调整筹资策略，强调供应商多元化和本地合格评估，以降低贸易波动带来的风险。

将产品形式、聚合物选择和特定应用要求与最终用户的采购和认证优先事项连结起来的多维细分方法。

有效的市场区隔应明确技术要求、采购实际情况和最终用户需求之间的交集，从而推动产品开发、供应商合作和商业化策略。在考虑一次性玻璃瓶、硬质容器和一次性包装袋等产品类型之间的差异时，决策者必须评估每种形式如何支援无菌转移、操作的人体工学以及与现有製程设备的整合。一次性玻璃瓶通常用作取样和储存工作流程中的中间容器，硬质容器可为运输敏感材料提供更优异的机械保护，而一次性包装袋则可提高封闭式系统中的换型效率并减轻清洁负担。

区域供应、监管和永续性趋势应影响全球市场生物製程容器的筹资策略和復原计画。

区域趋势对供应商策略、监管预期和物流复杂性有显着影响，这些因素都应体现在采购选择和风险缓解计画中。在美洲，特定聚合物和薄膜领域强大的本土製造能力有助于加快合格週期并缩短前置作业时间，使买家能够优先选择交货短、生产批量灵活的供应商。该地区还聚集了大量的契约製造製造商和生物製药研发中心，推动了对扩充性的一次性解决方案和严格文件的需求，以满足临床试验和商业化进程。

技术差异化、共同开发和供应连续性是竞争力的驱动力，它们决定了供应商的选择和长期采购关係。

主要製造商和零件供应商之间的竞争格局主要体现在透过品质系统、技术支援和垂直整合来实现差异化。投资于材料科学、专有阻隔膜和检验的灭菌工艺的公司，比那些优先考虑快速认证和降低污染风险的客户更具优势。服务是竞争的另一个向度。能够提供全面文件、专门的技术检验支援和灵活生产计划的供应商更有可能与生物製药公司和契约製造签订长期合约。

将技术、品质和采购功能整合起来的实用措施，以增强供应商的韧性，加快验证速度，并优化整体拥有成本。

产业领导企业应在容器选择流程的早期阶段就采取协作方式，让技术、品质和采购部门的相关人员参与其中，以减少下游流程中的返工和验证延误。协调跨职能团队可确保规格一致性，加速供应商合格，并促进更顺畅的技术转移和规模化生产。此外，企业应优先选择能够提供透明文件、全面的提取和洗脱数据以及监管申报支持的供应商，以降低从临床到商业化过渡期间的风险。

我们高度透明的混合方法研究框架，结合了二手资讯、相关人员访谈和严格的资料检验，为决策者提供可操作的见解。

本概要的研究采用了一种结构化的混合方法，旨在捕捉技术细节、商业性趋势和区域供应的考量。研究首先对行业出版物、监管指导文件、专利申请和供应商技术文献进行了全面的二次检索，以整体情况容器的形状、材料和灭菌方法。这项基准分析为后续主要研究中使用的访谈指南和定量调查问卷的製定奠定了基础。

从全面的观点与供应商的综合伙伴关係、材料策略和区域采购决策如何决定营运韧性和竞争地位。

总而言之，生物製程容器产业正从商品化的供应关係转向以技术伙伴关係、监管和供应链务实性为特征的模式。材料选择、灭菌相容性和形状选择如今对下游製程（例如验证、污染控制和物流灵活性）都具有重要影响。关税趋势和区域产能转移进一步加剧了采购决策的复杂性，使得供应商透明度和地理多元化对于风险管理至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按容器类型分類的生物製程容器市场

  • 二维生物製程容器
  • 3D生物加工容器
  • 刚性生物製程容器
  • 专用容器
    • 玻璃瓶
    • 管瓶和安瓿

第九章：生物製程容器市场：依材料分类

  • 乙烯-醋酸乙烯酯
  • 萤光树脂
    • 聚四氟乙烯
    • Polyvinylidene氟乙烯
  • PE多层结构
    • EVOH隔离层
    • PA/尼龙增强层
    • ULDPE/LLDPE接触层
  • 聚丙烯
  • 聚氯乙烯

第十章：生物製程容器市场：依容量划分

  • 10-50升
  • 200-500升
  • 50-200升
  • 500-1000公升
  • 少于10公升
  • 超过1000公升

第十一章：以灭菌方法分類的生物製程容器市场

  • 化学灭菌
  • 放射线杀菌
    • 电子束
    • 伽玛射线照射
    • X射线照射
  • 热力灭菌

第十二章：生物製程容器市场：依应用领域划分

  • 下游工艺
    • 层析法中间体
    • 配方
    • 收穫和澄清
    • 超过滤/透析
    • 病毒灭活
  • 灌装/包装
    • 原料药的储存
    • 最终药品
  • 仓储和运输
    • 原料药的冷冻
    • 院际转运
  • 上游工程
    • 细胞培养与发酵
    • 培养基製备
    • 种子培养及接种物生长

第十三章：生物工艺容器市场：依最终用户划分

  • 学术和研究机构
  • 生物製药和疫苗生产商
  • 契约製造组织
  • 诊断检测实验室

第十四章：生物工艺容器市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：生物工艺容器市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：生物製程容器市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国生物製程容器市场

第十八章：中国生物製程容器市场

第十九章 竞争情势

  • 2024年市场集中度分析
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2024 年
  • 2024年产品系列分析
  • 基准分析，2024 年
  • ALLpaQ Packaging Group Ltd
  • Avantor, Inc.
  • Compagnie de Saint-Gobain SA
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Entegris, Inc.
  • Lonza Group AG
  • Meissner Corporation
  • Merck KGaA
  • Parker-Hannifin Corporation
  • Repligen Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-BB6269D136A1

The Bioprocess Containers Market was valued at USD 6.09 billion in 2024 and is projected to grow to USD 7.40 billion in 2025, with a CAGR of 22.33%, reaching USD 20.44 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 6.09 billion
Estimated Year [2025] USD 7.40 billion
Forecast Year [2030] USD 20.44 billion
CAGR (%) 22.33%

A concise orientation to the evolving role of bioprocess containers in ensuring process integrity, regulatory readiness, and operational scalability for decision-makers

The bioprocess container landscape sits at the intersection of rapid scientific progress and heightened operational scrutiny. As biologics development and manufacturing evolve, containers that historically served as passive vessels are now integral to process integrity, contamination control, and supply chain resilience. These containers support a range of activities from small-scale academic experimentation to full-scale contract manufacturing, and their selection influences process reproducibility, validation timelines, and downstream logistics.

Recent innovations in polymer science, sterilization modalities, and single-use integration have expanded the functional role of containers, prompting stakeholders to reassess procurement strategies and technical specifications. At the same time, procurement teams face increased pressure to balance cost, regulatory compliance, and environmental considerations. This dynamic compels organizations to align technical teams, quality assurance, and purchasing early in the product development lifecycle to avoid costly redesigns or qualification delays.

In this environment, a clear strategic framework helps organizations prioritize investments in container technologies that enable scalability, reduce contamination risk, and simplify validation. This summary synthesizes the forces shaping vendor selection, material choice, application-specific requirements, and regional supply dynamics to guide leaders who must make timely, defensible decisions across research, clinical, and commercial operations.

Key structural and technological inflection points that are reshaping supplier dynamics, material priorities, and regulatory expectations across bioprocess container usage

The landscape for bioprocess containers is undergoing several transformative shifts that are redefining supplier relationships, design priorities, and procurement logic. First, the migration toward single-use systems and hybrid processing has accelerated, forcing manufacturers and integrators to emphasize component compatibility, connector standardization, and supply continuity. This evolution is reshaping how pharmaceutical developers approach process transfer and technology qualification, with downstream effects on validation strategies and vendor audits.

Second, material science advances are driving differentiation through films and polymers engineered for extractables and leachables performance, mechanical resilience, and sterilization tolerance. As a result, specifications are increasingly granular, and cross-functional teams must codify acceptance criteria earlier in development. Third, regulatory scrutiny over contamination control and supply chain traceability has intensified, prompting more rigorous documentation and supplier transparency requirements. This is prompting many organizations to demand enhanced quality agreements, chain-of-custody records, and batch-specific certification.

Fourth, commercialization pathways and contract manufacturing models are compelling end users to prioritize containers that enable rapid scale-up while minimizing requalification. Finally, environmental and circularity considerations are nudging manufacturers to explore recyclable polymers and take-back programs, though economic and technical barriers remain. Together, these shifts demand that stakeholders adopt proactive supply strategies, integrate technical and procurement decision-making, and remain adaptable to rapid technological and regulatory change.

How 2025 tariff developments are recalibrating sourcing choices, supplier qualification imperatives, and supply chain resilience strategies across the bioprocess container value chain

Tariff actions and trade policy changes announced in 2025 have a multilayered effect on the bioprocess container ecosystem, influencing sourcing decisions, cost structures, and supplier footprint planning. For organizations that rely on cross-border supply chains, increased duties raise the effective landed cost of imported components and finished containers, which in turn pressures margins or forces buyers to reconsider supplier selection criteria. In response, several buyers are recalibrating procurement strategies to emphasize vendor diversification and local qualification to reduce exposure to trade volatility.

The tariff environment also affects component suppliers differently depending on material composition and manufacturing location. Manufacturers that rely on imported resin feedstocks or specialized films can experience higher input costs that cascade along the value chain, prompting renegotiation of supply contracts or exploration of alternative feedstock sources. Concurrently, manufacturers with domestic production capabilities may leverage nearshoring as a competitive advantage, offering shorter lead times and reduced exposure to cross-border friction, which has become an increasingly important selection factor during qualification.

Beyond immediate cost pressure, tariffs can accelerate structural changes such as strategic partnerships, joint ventures, and capacity investments in import-competing geographies. Buyers must weigh the benefits of cost predictability and supply resilience against the potential need for revalidation when qualifying new suppliers or materials. Ultimately, the cumulative impact of tariff shifts underscores the importance of scenario planning, robust supplier qualification processes, and the integration of trade considerations into technical decision-making.

A multidimensional segmentation approach linking product formats, polymer choices, and application-specific demands to procurement and qualification priorities for end users

Effective segmentation illuminates where technical requirements intersect with procurement realities and end-user needs, and it should drive product development, supplier engagement, and commercialization strategies. When considering product type distinctions such as Disposable Carboys, Rigid Containers, and Single-Use Bags, decision-makers must evaluate how each format supports aseptic transfer, handling ergonomics, and integration with existing process skids. Disposable Carboys often serve as intermediary vessels in sampling and storage workflows; rigid containers can offer superior mechanical protection for transport-sensitive materials; and single-use bags enable leaner changeover and reduced cleaning burden for closed systems.

Material choice is another critical axis: Polyethylene, Polypropylene, and Polyvinyl Chloride each offer unique chemical resistance, flexibility, and thermal tolerance that affect sterilization compatibility and extractables profiles. Polyethylene and polypropylene variants are commonly selected for single-use applications due to favorable weldability and low extractables, while polyvinyl chloride still finds use where flexibility and cost considerations dominate. Application-specific segmentation further refines requirements. In Cell Culture applications-covering Insect Culture, Mammalian Culture, and Microbial Culture-biological sensitivity and nutrient compositions dictate container surface treatments, gas transfer considerations, and cleanliness thresholds. Fermentation use cases split between Cell-Based Fermentation and Microbial Fermentation, each presenting divergent shear, mixing, and sampling demands. Sampling and Storage & Transport use cases emphasize container closure integrity, labeling, and traceability.

End-user type shapes procurement lead times, documentation expectations, and volume patterns. Academic & Research Institutes, which include Government Research Institutes and University Laboratories, prioritize flexibility, short-run availability, and cost-effective validation, while Biopharmaceutical Companies demand rigorous quality systems, vendor audits, and long-term supply commitments. Contract Manufacturing Organizations require containers that support rapid changeover, validated interchangeability, and consistent lot-to-lot performance. Capacity segmentation-ranging from Up To 50 Liters to 50 To 200 Liters and Above 200 Liters-further dictates material thickness, port configuration, and handling requirements. Sterilization method selection, whether Autoclavable, EtO Sterilization, or Gamma Sterilization, imposes material and design constraints that must be reconciled with extractables, packaging, and labeling protocols. Together, these segmentation lenses create a multidimensional specification matrix that manufacturers and purchasers must navigate when matching container solutions to process needs.

Regional supply, regulatory, and sustainability dynamics that should shape sourcing strategies and resilience planning for bioprocess container procurement across global markets

Regional dynamics exert material influence on supplier strategies, regulatory expectations, and logistical complexity, and they should inform both sourcing choices and risk mitigation planning. In the Americas, strong domestic manufacturing capacity in certain polymer and film categories supports quicker qualification cycles and shorter lead times, creating opportunities for buyers to prioritize suppliers capable of near-term delivery and flexible production runs. This region also exhibits a high density of contract manufacturers and biopharmaceutical development centers, increasing demand for scalable single-use solutions and rigorous documentation to meet clinical and commercialization timelines.

Europe, Middle East & Africa presents a heterogeneous set of market drivers where regulatory frameworks and environmental policy considerations vary across jurisdictions. In many European markets, heightened emphasis on sustainability and extended producer responsibility drives buyer interest in recyclable materials and circularity pilots, while regulatory agencies expect comprehensive extractables and leachables data for sterile processing components. The Middle East and Africa show growing demand driven by capacity expansion and investment in local manufacturing, but limited local supplier ecosystems often result in reliance on imports and longer qualification lead times.

Asia-Pacific remains a strategic focal point due to its large-scale manufacturing base, rapid capacity additions, and a deep supplier network for polymers and finished components. Procurement teams often find competitive pricing and breadth of options in this region, yet they must balance cost advantages against potential trade policy exposure and variable quality systems. Across all regions, logistics constraints, customs practices, and regional sterilization capabilities affect selection and inventory strategy, so cross-geography sourcing strategies must account for both technical compatibility and operational resilience.

Competitive dynamics driven by technical differentiation, collaborative development, and supply continuity that determine supplier selection and long-term procurement relationships

Competitive dynamics among leading manufacturers and component suppliers center on differentiation through quality systems, technical support, and vertical integration. Companies that invest in material science, proprietary barrier films, and validated sterilization processes gain an edge with customers that prioritize rapid qualification and reduced contamination risk. Another axis of competition is service: suppliers that provide comprehensive documentation, dedicated technical validation support, and flexible production scheduling are more likely to secure long-term agreements with biopharmaceutical firms and contract manufacturers.

Strategic partnerships and collaborative development agreements are increasingly common as suppliers seek to embed their products earlier in client development pipelines. These relationships can include co-development of customized container formats, joint extractables and leachables testing, and coordinated regulatory submissions that streamline client adoption. Additionally, some suppliers are vertically integrating resin supply or film extrusion capabilities to control input quality and reduce lead time variability, which appeals to buyers focused on continuity and traceability.

Mergers and acquisitions remain a tactical option for companies seeking scale, expanded geographic footprint, or complementary technology stacks. However, customers are more sensitive to continuity of supply during integration periods, so transparency about capacity planning and quality control during transactional transitions is critical. Ultimately, the competitive landscape favors suppliers that combine robust quality systems, technical partnership willingness, and responsive supply chain management.

Actionable measures for integrating technical, quality, and procurement functions to enhance supplier resilience, accelerate validation, and optimize total cost of ownership

Industry leaders should adopt a coordinated approach that embeds technical, quality, and procurement stakeholders early in the container selection process to reduce downstream rework and validation delays. Aligning cross-functional teams ensures specification convergence and accelerates supplier qualification, enabling smoother technology transfer and scale-up. Additionally, firms should prioritize suppliers that offer transparent documentation, comprehensive extractables and leachables data, and support for regulatory submissions to reduce risk during clinical and commercial transitions.

To strengthen supply resilience, diversify the supplier base across geographies and technologies while maintaining a small set of fully qualified alternate vendors. This dual strategy preserves negotiation leverage and reduces dependence on a single manufacturing node without overwhelming validation capacities. Invest in supplier performance metrics and cadence-based reviews to identify emerging capacity constraints early, and incorporate trade policy scenario planning into procurement decision frameworks.

On the technical front, prioritize materials and designs compatible with multiple sterilization methods where feasible, as this flexibility can simplify qualification across manufacturing sites and reduce bottlenecks. Evaluate opportunities for pilot partnerships focused on recyclability and lifecycle management where regional policy or customer demands make circularity a near-term priority. Finally, integrate tariff and trade considerations into total-cost-of-ownership models to ensure procurement decisions reflect landed cost, risk, and validation overhead rather than unit price alone.

A transparent mixed-methods research framework combining secondary intelligence, stakeholder interviews, and rigorous data validation to support actionable insights for decision-makers

The research behind this summary employed a structured mixed-methods approach designed to capture technical nuance, commercial dynamics, and regional supply considerations. The process began with a comprehensive secondary review of industry publications, regulatory guidance documents, patent filings, and supplier technical literature to map the landscape of container formats, materials, and sterilization methods. This baseline analysis informed the development of interview guides and quantitative questionnaires used during primary research.

Primary research included interviews with senior technical leaders, quality assurance professionals, procurement officers, and manufacturing specialists across end-user segments including academic institutions, biopharmaceutical companies, and contract manufacturers. These conversations elicited information on specification priorities, qualification timelines, supplier evaluation criteria, and logistical constraints. To validate findings, triangulation was applied by cross-referencing interview insights with supplier documentation and observed procurement patterns.

Analytical rigor was maintained through standardized coding of qualitative data, quality checks on supplier claims, and peer review of interpretations by subject-matter experts. Limitations include the evolving nature of trade policy and the variability of regional sterilization infrastructure, which may change rapidly. To mitigate these risks, the methodology emphasizes scenario-based analysis and supplier performance indicators that can be updated as new data emerges.

A summative perspective on how integrated supplier partnerships, material strategy, and regional sourcing decisions together determine operational resilience and competitive positioning

In summary, the bioprocess container sector is transitioning from a commoditized supply relationship to one characterized by technical partnerships, regulatory scrutiny, and supply chain pragmatism. Material selection, sterilization compatibility, and format choice now carry downstream implications for validation, contamination control, and logistical agility. Tariff developments and regional capacity shifts further complicate procurement decisions, making supplier transparency and geographic diversification essential to risk management.

Organizations that proactively align cross-functional stakeholders, qualify alternate suppliers, and prioritize containers compatible with multiple sterilization pathways will be better positioned to navigate both technical and commercial uncertainties. Strategic investment in supplier partnerships and material innovation can yield operational advantages, while thoughtful incorporation of trade and regional dynamics into procurement models will reduce exposure to sudden cost or lead-time shocks. Ultimately, the most resilient organizations will be those that treat container selection as an integrated strategic decision, not simply a purchasing execution, thereby converting supply chain complexity into a competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioprocess Containers Market, by Container Type

  • 8.1. 2D Bioprocess Containers
  • 8.2. 3D Bioprocess Containers
  • 8.3. Rigid Bioprocess Containers
  • 8.4. Specialty Containers
    • 8.4.1. Carboys & Bottles
    • 8.4.2. Vials & Ampoules

9. Bioprocess Containers Market, by Material

  • 9.1. Ethylene Vinyl Acetate
  • 9.2. Fluoropolymers
    • 9.2.1. Polytetrafluoroethylene
    • 9.2.2. Polyvinylidene Fluoride
  • 9.3. PE-Based Multilayer
    • 9.3.1. EVOH Barrier Layer
    • 9.3.2. PA/Nylon Reinforcement Layer
    • 9.3.3. ULDPE/LLDPE Contact Layer
  • 9.4. Polypropylene
  • 9.5. Polyvinyl Chloride

10. Bioprocess Containers Market, by Capacity

  • 10.1. 10-50 Liters
  • 10.2. 200 - 500 Liters
  • 10.3. 50 - 200 Liters
  • 10.4. 500 - 1000 Liters
  • 10.5. < 10 Liters
  • 10.6. > 1000 Liters

11. Bioprocess Containers Market, by Sterilization Method

  • 11.1. Chemical Sterilization
  • 11.2. Radiation-Based Sterilization
    • 11.2.1. Electron Beam
    • 11.2.2. Gamma Irradiation
    • 11.2.3. X-Ray Irradiation
  • 11.3. Thermal Sterilization

12. Bioprocess Containers Market, by Application

  • 12.1. Downstream Processing
    • 12.1.1. Chromatography Intermediates
    • 12.1.2. Formulation
    • 12.1.3. Harvest & Clarification
    • 12.1.4. Ultrafiltration/Diafiltration
    • 12.1.5. Viral Inactivation
  • 12.2. Fill-Finish
    • 12.2.1. Bulk Drug Substance Storage
    • 12.2.2. Final Drug Product
  • 12.3. Storage & Transport
    • 12.3.1. Drug Substance Freezing
    • 12.3.2. Inter-Facility Transfer
  • 12.4. Upstream Processing
    • 12.4.1. Cell Culture & Fermentation
    • 12.4.2. Media Preparation
    • 12.4.3. Seed Train & Inoculum Expansion

13. Bioprocess Containers Market, by End User

  • 13.1. Academic & Research Institutes
  • 13.2. Biopharmaceutical & Vaccine Manufacturers
  • 13.3. Contract Manufacturing Organizations
  • 13.4. Diagnostic Laboratories

14. Bioprocess Containers Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioprocess Containers Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioprocess Containers Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Bioprocess Containers Market

18. China Bioprocess Containers Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2024
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2024
  • 19.3. Product Portfolio Analysis, 2024
  • 19.4. Benchmarking Analysis, 2024
  • 19.5. ALLpaQ Packaging Group Ltd
  • 19.6. Avantor, Inc.
  • 19.7. Compagnie de Saint-Gobain S.A.
  • 19.8. Corning Incorporated
  • 19.9. Cytiva by Danaher Corporation
  • 19.10. Entegris, Inc.
  • 19.11. Lonza Group AG
  • 19.12. Meissner Corporation
  • 19.13. Merck KGaA
  • 19.14. Parker-Hannifin Corporation
  • 19.15. Repligen Corporation
  • 19.16. Sartorius AG
  • 19.17. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPROCESS CONTAINERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL BIOPROCESS CONTAINERS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 14. CHINA BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 2D BIOPROCESS CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 2D BIOPROCESS CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 2D BIOPROCESS CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 3D BIOPROCESS CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 3D BIOPROCESS CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 3D BIOPROCESS CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RIGID BIOPROCESS CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RIGID BIOPROCESS CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RIGID BIOPROCESS CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CARBOYS & BOTTLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CARBOYS & BOTTLES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CARBOYS & BOTTLES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIALS & AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIALS & AMPOULES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIALS & AMPOULES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY EVOH BARRIER LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY EVOH BARRIER LAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY EVOH BARRIER LAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PA/NYLON REINFORCEMENT LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PA/NYLON REINFORCEMENT LAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY PA/NYLON REINFORCEMENT LAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULDPE/LLDPE CONTACT LAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULDPE/LLDPE CONTACT LAYER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULDPE/LLDPE CONTACT LAYER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 10-50 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 10-50 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 10-50 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 200 - 500 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 200 - 500 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 200 - 500 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 50 - 200 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 50 - 200 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 50 - 200 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 500 - 1000 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 500 - 1000 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY 500 - 1000 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY < 10 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY < 10 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY < 10 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY > 1000 LITERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY > 1000 LITERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY > 1000 LITERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHEMICAL STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHEMICAL STERILIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHEMICAL STERILIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY X-RAY IRRADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY X-RAY IRRADIATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY X-RAY IRRADIATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY THERMAL STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY THERMAL STERILIZATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY THERMAL STERILIZATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 96. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 97. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 99. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHROMATOGRAPHY INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 100. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHROMATOGRAPHY INTERMEDIATES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CHROMATOGRAPHY INTERMEDIATES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 103. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY HARVEST & CLARIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 106. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY HARVEST & CLARIFICATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY HARVEST & CLARIFICATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULTRAFILTRATION/DIAFILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 109. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULTRAFILTRATION/DIAFILTRATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 110. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ULTRAFILTRATION/DIAFILTRATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIRAL INACTIVATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 112. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIRAL INACTIVATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY VIRAL INACTIVATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 115. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 118. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BULK DRUG SUBSTANCE STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 119. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BULK DRUG SUBSTANCE STORAGE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 120. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BULK DRUG SUBSTANCE STORAGE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FINAL DRUG PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 122. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FINAL DRUG PRODUCT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 123. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY FINAL DRUG PRODUCT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 124. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 125. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 128. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DRUG SUBSTANCE FREEZING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 129. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DRUG SUBSTANCE FREEZING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DRUG SUBSTANCE FREEZING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY INTER-FACILITY TRANSFER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 132. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY INTER-FACILITY TRANSFER, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY INTER-FACILITY TRANSFER, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 135. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 138. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CELL CULTURE & FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 139. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CELL CULTURE & FERMENTATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 140. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CELL CULTURE & FERMENTATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 142. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MEDIA PREPARATION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 143. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY MEDIA PREPARATION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 144. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SEED TRAIN & INOCULUM EXPANSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 145. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SEED TRAIN & INOCULUM EXPANSION, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 146. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY SEED TRAIN & INOCULUM EXPANSION, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 147. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 149. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 150. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BIOPHARMACEUTICAL & VACCINE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 152. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BIOPHARMACEUTICAL & VACCINE MANUFACTURERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY BIOPHARMACEUTICAL & VACCINE MANUFACTURERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 154. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 155. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 157. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 158. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 159. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 160. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 161. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 162. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 164. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 166. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 167. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 168. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 170. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 172. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 173. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 174. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 175. AMERICAS BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 177. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 179. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 192. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 194. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 195. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 196. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 226. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 227. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 228. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 230. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 232. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 233. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 234. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 235. EUROPE BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 237. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 239. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 240. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 241. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 242. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 243. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 245. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 247. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 248. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 249. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 250. MIDDLE EAST BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 252. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 254. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 255. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 256. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 257. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 258. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 259. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 260. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 262. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 263. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 264. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 265. AFRICA BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. GLOBAL BIOPROCESS CONTAINERS MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 282. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 283. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 285. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 286. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 287. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 288. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 289. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 290. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 291. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 293. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY FILL-FINISH, 2018-2030 (USD MILLION)
  • TABLE 294. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY STORAGE & TRANSPORT, 2018-2030 (USD MILLION)
  • TABLE 295. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2030 (USD MILLION)
  • TABLE 296. ASEAN BIOPROCESS CONTAINERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 298. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY CONTAINER TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY SPECIALTY CONTAINERS, 2018-2030 (USD MILLION)
  • TABLE 300. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 301. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY FLUOROPOLYMERS, 2018-2030 (USD MILLION)
  • TABLE 302. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY PE-BASED MULTILAYER, 2018-2030 (USD MILLION)
  • TABLE 303. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 304. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY STERILIZATION METHOD, 2018-2030 (USD MILLION)
  • TABLE 305. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY RADIATION-BASED STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 306. GCC BIOPROCESS CONTAINERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. GCC BIOPROCESS CONTAINERS MARKET SIZ